Securities fraud attorneys continue to investigate claims on behalf of investors who suffered significant losses in UBS Willow Fund investments. Despite the fact that many customers were allegedly told the fund was safe and low-risk, it suffered a decline of around 80 percent. In addition, the fund may have deviated from the investment strategy it originally disclosed to investors, and this alleged deviation may have played a significant role in the decline of the fund.
Created as a private hedge fund in 2000, the UBS Willow Fund was sold by UBS Financial Services. Reportedly, an announcement in October 2012 stated that the UBS Willow Fund would be liquidated. On September 6, 2013, the fund’s shareholder report stated, “The fund does not hold investments as of June 30, 2013.”
It’s possible that UBS did not adequately disclose the risks of the fund when making recommendations. Furthermore, many of the investors who received recommendations to invest in the fund reportedly had low risk tolerances and were seeking stable income. According to stock fraud lawyers, firms have an obligation to fully disclose all the risks of a given investment when making recommendations, and those recommendations must be suitable for the individual investor receiving the recommendation given their age, investment objectives and risk tolerance.
In addition, securities arbitration lawyers say that the portfolios of some investors may have been over-concentrated in the UBS Willow Fund. Finally, the fund may have strayed from its disclosed strategy, which was to invest in distressed debt, making speculations about foreign sovereign debt credit default swaps instead.
If you suffered significant losses in the UBS Willow Fund because of an unsuitable recommendation, you may be able to recover your losses through Financial Industry Regulatory Authority arbitration. To find out more about your legal rights and options, contact a stock fraud lawyer at Law Office of Christopher J. Gray, P.C. at (866) 966-9598 or email@example.com for a no-cost, confidential consultation.